Satoru Miyahara

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Yuichiro Doki · 6 shared papers, 2024–2026 · strength 1.37
   • Paper Discrepancy Between Radiographic and Pathological Response Assessment in Neoadjuvant Treatment for Pancreatic Cancer: A… DOI 10.1002/ags3.70047↗
   • Paper Prognostic impact of post-neoadjuvant CA19-9 values in pancreatic cancer: more pronounced following neoadjuvant chemoth… DOI 10.1016/j.pan.2025.06.016↗
   • Paper Response to the letter to the editor: "Refining the prognostic utility of CA19-9 in neoadjuvant therapy for pancreatic … DOI 10.1016/j.pan.2025.09.033↗
2. Hirofumi Akita · 6 shared papers, 2024–2026 · strength 1.37
   • Paper Discrepancy Between Radiographic and Pathological Response Assessment in Neoadjuvant Treatment for Pancreatic Cancer: A… DOI 10.1002/ags3.70047↗
   • Paper Prognostic impact of post-neoadjuvant CA19-9 values in pancreatic cancer: more pronounced following neoadjuvant chemoth… DOI 10.1016/j.pan.2025.06.016↗
   • Paper Response to the letter to the editor: "Refining the prognostic utility of CA19-9 in neoadjuvant therapy for pancreatic … DOI 10.1016/j.pan.2025.09.033↗
3. Yoshito Tomimaru · 6 shared papers, 2024–2026 · strength 1.37
   • Paper Discrepancy Between Radiographic and Pathological Response Assessment in Neoadjuvant Treatment for Pancreatic Cancer: A… DOI 10.1002/ags3.70047↗
   • Paper Prognostic impact of post-neoadjuvant CA19-9 values in pancreatic cancer: more pronounced following neoadjuvant chemoth… DOI 10.1016/j.pan.2025.06.016↗
   • Paper Response to the letter to the editor: "Refining the prognostic utility of CA19-9 in neoadjuvant therapy for pancreatic … DOI 10.1016/j.pan.2025.09.033↗
4. Daisaku Yamada · 6 shared papers, 2024–2026 · strength 1.37
   • Paper Discrepancy Between Radiographic and Pathological Response Assessment in Neoadjuvant Treatment for Pancreatic Cancer: A… DOI 10.1002/ags3.70047↗
   • Paper Prognostic impact of post-neoadjuvant CA19-9 values in pancreatic cancer: more pronounced following neoadjuvant chemoth… DOI 10.1016/j.pan.2025.06.016↗
   • Paper Response to the letter to the editor: "Refining the prognostic utility of CA19-9 in neoadjuvant therapy for pancreatic … DOI 10.1016/j.pan.2025.09.033↗
5. Hidetoshi Eguchi · 4 shared papers, 2024–2025 · strength 0.89
   • Paper Discrepancy Between Radiographic and Pathological Response Assessment in Neoadjuvant Treatment for Pancreatic Cancer: A… DOI 10.1002/ags3.70047↗
   • Paper Response to the letter to the editor: "Refining the prognostic utility of CA19-9 in neoadjuvant therapy for pancreatic … DOI 10.1016/j.pan.2025.09.033↗
   • Paper Organ-specific variations in tumor marker dynamics in postoperative pancreatic cancer recurrence: Trends in lung and li… DOI 10.1016/j.suronc.2024.102103↗
6. Kazuki Sasaki · 4 shared papers, 2024–2026 · strength 0.87
   • Paper Prognostic impact of post-neoadjuvant CA19-9 values in pancreatic cancer: more pronounced following neoadjuvant chemoth… DOI 10.1016/j.pan.2025.06.016↗
   • Paper Exosomal microRNA-4800-3p in portal vein blood promotes liver metastasis in pancreatic cancer by targeting PLAA. DOI 10.1038/s41598-026-48779-7↗
   • Paper Organ-specific variations in tumor marker dynamics in postoperative pancreatic cancer recurrence: Trends in lung and li… DOI 10.1016/j.suronc.2024.102103↗
7. Hidenori Takahashi · 3 shared papers, 2024–2025 · strength 0.64
   • Paper Discrepancy Between Radiographic and Pathological Response Assessment in Neoadjuvant Treatment for Pancreatic Cancer: A… DOI 10.1002/ags3.70047↗
   • Paper Organ-specific variations in tumor marker dynamics in postoperative pancreatic cancer recurrence: Trends in lung and li… DOI 10.1016/j.suronc.2024.102103↗
   • Paper ASO Author Reflections: A Novel Combination Index of Sialyl-Lewis Antigen-Related Tumor Markers Enhances Predictive Sig… DOI 10.1245/s10434-024-15021-5↗
8. Yoshifumi Iwagami · 3 shared papers, 2024–2026 · strength 0.63
   • Paper Exosomal microRNA-4800-3p in portal vein blood promotes liver metastasis in pancreatic cancer by targeting PLAA. DOI 10.1038/s41598-026-48779-7↗
   • Paper Organ-specific variations in tumor marker dynamics in postoperative pancreatic cancer recurrence: Trends in lung and li… DOI 10.1016/j.suronc.2024.102103↗
   • Paper ASO Author Reflections: A Novel Combination Index of Sialyl-Lewis Antigen-Related Tumor Markers Enhances Predictive Sig… DOI 10.1245/s10434-024-15021-5↗
9. Shinichiro Hasegawa · 2 shared papers, 2024–2026 · strength 0.42
   • Paper Exosomal microRNA-4800-3p in portal vein blood promotes liver metastasis in pancreatic cancer by targeting PLAA. DOI 10.1038/s41598-026-48779-7↗
   • Paper ASO Author Reflections: A Novel Combination Index of Sialyl-Lewis Antigen-Related Tumor Markers Enhances Predictive Sig… DOI 10.1245/s10434-024-15021-5↗
10. Hidetoshi Eguchi · 1 shared paper, 2025 · strength 0.25
    • Paper Prognostic impact of post-neoadjuvant CA19-9 values in pancreatic cancer: more pronounced following neoadjuvant chemoth… DOI 10.1016/j.pan.2025.06.016↗
11. Tadafumi Asaoka · 1 shared paper, 2026 · strength 0.24
    • Paper Exosomal microRNA-4800-3p in portal vein blood promotes liver metastasis in pancreatic cancer by targeting PLAA. DOI 10.1038/s41598-026-48779-7↗
12. Hidetoshi Eguchi · 1 shared paper, 2026 · strength 0.24
    • Paper Exosomal microRNA-4800-3p in portal vein blood promotes liver metastasis in pancreatic cancer by targeting PLAA. DOI 10.1038/s41598-026-48779-7↗
13. Yosuke Mukai · 1 shared paper, 2024 · strength 0.18
    • Paper ASO Author Reflections: A Novel Combination Index of Sialyl-Lewis Antigen-Related Tumor Markers Enhances Predictive Sig… DOI 10.1245/s10434-024-15021-5↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.